Beta Bionics develops the iLet Bionic Pancreas, an insulin delivery system that autonomously calculates and administers insulin doses based on real-time data from continuous glucose monitors. This technology eliminates the need for manual carb counting and insulin dose adjustments, providing a streamlined solution for diabetes management.
Funding
$60M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
WMFounders
Product
Problem
Managing type 1 diabetes requires constant monitoring of glucose levels and manual adjustment of insulin dosages, creating a significant cognitive and emotional burden for patients. Traditional insulin pumps necessitate meticulous carbohydrate counting and frequent corrections, making it difficult for individuals to maintain consistent glycemic control and avoid complications.
Solution
Beta Bionics offers the iLet Bionic Pancreas, an automated insulin delivery system designed to simplify diabetes management. The iLet utilizes real-time data from continuous glucose monitors (CGMs) to autonomously calculate and administer insulin doses, eliminating the need for manual carb counting in most cases. The system continuously learns an individual's insulin needs, adapting to their unique requirements and reducing the burden of decision-making. The iLet integrates with Dexcom CGMs and FreeStyle Libre 3 sensors, providing users with a choice of compatible devices.
Target Audience
The iLet Bionic Pancreas is intended for individuals with type 1 diabetes, aged six years and older, who require automated insulin delivery to manage their condition.
Features
- Automated insulin delivery system using real-time data from Dexcom CGM or FreeStyle Libre 3 Plus sensor
- Continuous learning algorithm adapts to individual insulin needs
- Eliminates the need for manual carb counting and correction boluses in most cases
- Bionic Circle app allows users to invite up to 10 friends and family members to monitor their glucose levels
- iLet Mirror Display and Pause Insulin features available through app upgrade
- Color iLet version available with a color screen and brighter display